Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo

Cancer Letters

Volumn 103, Issue 1, 1996, Pages 49-56

  Vincent, Timothy S ^a   Hazen Martin, Debra J ^a   Garvin, A Julian ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Autocrine; Insulin like growth factor ii; Suramin; Wilms' tumor

Indexed keywords

IODINE 125; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR; SURAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0029867888     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04186-9     Document Type: Article

References (25)

1. Williams, W.L. (1946) The effects of suramin (germanin), azo dyes, and vasodilators on mice with transplanted lymphosarcomas. Cancer Res., 6, 344-353.
2. Levine, A.M., Gill, P.S., Cohen, J., Hawkins, J.G., Formenti, S.C., Aguilar, S., Meyer, P.R., Krailo, M., Parker, J. and Rasheed, S. (1986) Suramin antiviral therapy in the acquired immunodeficiency syndrome. Ann. Intern. Med., 105, 32-37.
3. La Rocca, R.V., Stein, C.A. and Myers, C.E. (1990) Suramin: prototype of a new generation of antitumor compounds. Cancer Cells, 2, 106-115.
4. Rago, R., Mitchen, J., Cheng, A.-L., Oberley, T. and Wilding, G. (1991) Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer Res., 51, 6629-6635.
5. Daughaday, W.H. (1990) Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology, 127, 1-4.
6. Williams, L.T., Tremble, P.M., Lavin, M.F. and Sunday, M.E. (1984) Platelet-derived growth factor receptors form a high affinity state in membrane preparations. J. Biol. Chem., 259, 5287-5294.
7. Coffey, Jr., R.J., Leof, E.B., Shipley, G.D. and Moses, H.L. (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell. Physiol., 132, 143-148.
8. Hoffman, R. and Cameron, L. (1992) Characterization of a scintillation proximity assay to detect modulators of transforming growth factor a (TGFα) binding. Anal. Biochem., 203, 70-75.
9. Mills, G.B., Zhang, N., May, C., Hill, M. and Chung, A. (1990) Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression. Cancer Res., 50, 3036-3042.
10. Pollack, M. and Richard, M. (1990) Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells. J. Natl. Cancer Inst., 82, 1349-1352.
11. Minniti, C.P., Maggi, M. and Helman, L.J. (1992) Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop. Cancer Res., 52, 1830-1835.
12. Matsunaga, E. (1981) Genetics of Wilms' tumor. Hum. Genet., 57, 231-246.
13. Reeve, A.E., Eccles, M.R., Wilkins, R.J., Bell, G.I. and Millow, L.J. (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumor. Nature, 317, 258-260.
14. Scott, J., Cowell, J., Robertson, M.E., Priestley, L.M., Wadey, R., Hopkins, B., Pritchard, J., Bell, G.I., Rall, L.B., Graham, C.F. and Knott, T.J. (1985) Insulin-like growth factor-II gene expression in Wilms' tumor and embryonic tissues. Nature, 317, 260-262.
15. Gansler, T., Allen, K.D., Burant, C.F., Inabnett, T., Scott, A., Buse, M.G., Sens, D.A. and Garvin, A.J. (1988) Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors. Am. J. Pathol., 130, 431-435.
16. Gansler, T., Furlanetto, R., Gramling, T.S., Robinson, K.A., Blocker, N., Buse, M.G., Sens, D.A. and Garvin, A.J. (1989) Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. Am. J. Pathol., 135, 961-966.
17. Garvin, A.J., Sullivan, J.L., Bennett, D.D., Stanley, W.S., Inabnett, T. and Sens, D.A. (1987) The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor. Am. J. Pathol., 129, 353-363.
18. Zapf, J., Walter, H. and Froesch, E.R. (1981) Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J. Clin. Invest., 68, 1321-1330.
19. Voller, A. and Bidwell, D. (1986) Enzyme-linked immunosorbant assay. In: Manual of Clinical Laboratory Immunology. Editors: N.R. Rose, H. Friedman and J.L. Fahey. American Society for Microbiology, Washington, DC, pp. 99-109.
20. Vincent, T.S., Wülfert, E. and Merler, E. (1991) Inhibition of growth factor signaling pathways by lovastatin. Biochem. Biophys. Res. Commun., 180, 1284-1289.
21. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
22. Moxham, C. and Jacobs, S. (1992) Insulin-like growth factor receptors. In: The Insulin-like Growth Factors. Editor: P.N. Schofield. Oxford University Press, New York, pp. 80-109.
23. Middaugh, C.R., Mach, H., Burke, C.J., Volkin, D.B., Dabora, J.M., Tsai, P.K., Bruner, M.W., Ryan, J.A. and Marfia, K.E. (1992) Nature of the interaction of growth factors with suramin. Biochemistry, 31, 9016-9024.
24. La Rocca, R.V., Stein, C.A., Danesi, R. and Myers, C.E. (1990) Suramin, a novel antitumor compound. J. Steroid Biochem. Mol. Biol., 37, 893-898.
25. van Rijswijk, R.E.N., van Loenen, A.C., Wagstaff, J., Meijer, E., Lopez, R., van Groeningen, C.J., Heimans, J.J. and Pinedo, H.M. (1992) Suramin: rapid loading and weekly maintenance regimens for cancer patients. J. Clin. Oncol., 10, 1788-1794.